MYOMAR MOLECULAR
Myomar Molecular is developing a diagnostic tool to identify early stages of muscle atrophy. this technology will be used by physiotherapists and medical doctors to access therapy approaches, reduce hospitalization time, and analyze recovery progress.
MYOMAR MOLECULAR
Industry:
Health Care Health Diagnostics Medical
Status:
Active
Total Funding:
15 K USD
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
EyeNetra
EyeNetra is a developer of an eye diagnostics platform used to measure the correction of users' vision through smartphone-based technology.
Current Employees Featured
Founder
Investors List
Ready2Launch
Ready2Launch investment in Pre Seed Round - Myomar Molecular
More informations about "Myomar Molecular"
Myomar Molecular Inc.
Our approach is completely personalized, tailored to your unique molecular biomarkers related to muscle metabolism. By carefully balancing these biomarkers, you’ll be empowered to sustain optimal muscle health.See details»
Our Team - Myomar Molecular Inc.
Dr. Rafaela Andrade is the CEO and co-founder of Myomar Molecular. She has over 10 years’ experience studying cellular metabolism and molecular biology. She studied cancer cells metabolism during her PhD and completed several …See details»
Myomar Molecular - Crunchbase Company Profile
Myomar Molecular is developing a diagnostic tool to identify early stages of muscle atrophy. this technology will be used by physiotherapists and medical doctors to access therapy approaches, reduce hospitalization time, and …See details»
Myomar Molecular - LinkedIn
Myomar Molecular is developing a diagnostic tool to identify early stages of muscle atrophy. This technology will be used by physiotherapists and medical doctors to access therapy...See details»
Myomar Nears Commercialization, Almost $1M Raised
Nov 8, 2023 · Myomar, which is developing a urine test to monitor muscle degeneration, was founded in 2021 by Dalhousie University biochemist and molecular biology PhD Andrade. The company also conducted clinical trials of …See details»
For Healthcare — Myomar Molecular Inc.
Our muscle score is a combination of biomarkers of muscle metabolism and behaviour. The Myomar test is designed as a tool for monitoring muscle metabolism. Biomarker ranges have …See details»
Myomar Molecular Eyes Patent, Crowdfunding - Entrevestor
Feb 7, 2023 · Halifax biomarker-testing startup Myomar Molecular is ramping up clinical trials and preparing to file a patent application, as it eyes a possible crowdfunding campaign to raise …See details»
Myomar Wins Health Canada Nod - Entrevestor
Jun 6, 2024 · Myomar Molecular, which is developing tests for monitoring muscle health, has won Health Canada approval, clearing the way for it to begin selling its product to customers through healthcare providers, such as physiotherapy …See details»
Myomar Molecular - PitchBook
Myomar Molecular was founded in 2021. Where is Myomar Molecular headquartered? Myomar Molecular is headquartered in Halifax, Canada. What is the size of Myomar Molecular? Myomar Molecular has 9 total employees. …See details»
Rafaela Andrade - Co-Founder and CEO - Myomar Molecular
Myomar technology is a monitoring and predicting tool of muscle health, forecasting potential muscle degeneration and pinpoint actionable recommendations. We measure the variation of …See details»
Myomar Molecular closes $1.1 million to bring its …
Mar 1, 2024 · Halifax-based healthtech startup Myomar Molecular has closed $1.1 million CAD in pre-seed funding as it looks to commercialize its muscle health monitoring device. The pre-seed round comprises a mix of equity and …See details»
Dal postdoc wins Mitacs entrepreneurship award for world’s first …
May 23, 2023 · The ground-breaking technology behind Dr. Andrade’s fast-growing company Myomar Molecular Inc. identifies unique and specific molecular changes in urine that are …See details»
News Release — Myomar Molecular Inc.
Sep 13, 2024 · Myomar Molecular is an innovative company specializing in diagnostic solutions focused on muscle health. The company's proprietary urine test allows healthcare …See details»
Myomar Molecular - Funding, Financials, Valuation & Investors
Myomar Molecular is developing a diagnostic tool to identify early stages of muscle atrophy.See details»
Myomar Molecular Inc. - Creative Destruction Lab
Myomar Molecular is a health diagnostics company developing the first, non-invasive molecular detection device and multiplex test for muscle loss. Over 80 percent of hospitalizations related …See details»
Myomar Aims For Regulatory Approval This Summer
Mar 10, 2024 · Myomar Molecular hopes to use some of the $1.1 million funding round it just closed to win Health Canada approval for its muscle health test by the end of June, as the …See details»
Halifax researcher’s simple urine strip test measures muscle health ...
Oct 1, 2023 · Dr. Andrade, co-founder and CEO of Halifax-based startup Myomar Molecular Inc., developed the simple, at-home screening tool in consultation with Dr. John Frampton, …See details»
Co-Founder and CEO @ Myomar Molecular - Crunchbase
Rafaela Andrade is the Co-Founder and CEO at Myomar Molecular.See details»
Myomar Molecular - Products, Competitors, Financials, Employees ...
Myomar Molecular specializes in the development of diagnostic tools for muscle health within the healthcare and wellness sectors. The company's main offerings include technology that tracks …See details»
Let's do launch: How Myomar Molecular’s plans to get its “pee-on …
Oct 31, 2023 · Pee on a stick, give it to your doctor and, within a week, know how strong your muscles are. What could be simpler? In fact, Dalhousie University molecular biologist Rafaela …See details»